IL6 and cancer: Specifically, HSPCs were identified within the glioblastoma tumor microenvironment, further promoting glioblastoma cell proliferation and secreting pro-metastatic factors such as IL-6 and CCL2, alongside increased PDL1 expression by cancer cells.17